Trial intelligence / Profile preview

Bupivacaine versus bupivacaine + dexmedetomidine caudal epidural block for lumbosacral surgery

PACTR202308663873345Phase 4Completed

Sponsor
El-Demerdash Hospital
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of bupivacaine and dexmedetomidine in postoperative pain (2 arms), sponsored by El-Demerdash Hospital. Primary endpoint: Duration of postoperative analgesia. Started Apr 2023; status: completed.

02

Drugs

bupivacainedexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202308663873345.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202308663873345.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call